1 / 3

Analysis for OTC Pharmaceuticals Market in Latin America 201

The OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals Market in Latin America has also been witnessing the some key increased outsourcing of drug development activities. However, the stringent regulations are expected to pose a challenge to the growth of this market.

awrnr
Download Presentation

Analysis for OTC Pharmaceuticals Market in Latin America 201

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OTC Pharmaceuticals Market in Latin America 2014 – 2018 Order this report by calling +1 888 391 5441 or Send an email to sales@sandlerresearch.org with your contact details and questions if any. Published: Jan 2014 Single User PDF: US$ 2000 Corporate User PDF: US$ 3000 © SandlerResearch.org/ Contact sales@sandlerresearch.org

  2. OTC Pharmaceuticals Market in Latin America 2014 – 2018 Research analysts forecast the OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals Market in Latin America has also been witnessing the some key increased outsourcing of drug development activities. However, the stringent regulations are expected to pose a challenge to the growth of this market. This report, the OTC Pharmaceuticals Market in Latin America Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the OTC Pharmaceuticals Market in Latin America market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Request for Discount @ http://www.sandlerresearch.org/discount?rname=13308 Order this report by calling +1 888 391 5441 or Send an email to sales@sandlerresearch.orgwith your contact details and questions if any. © SandlerResearch.org/ Contact sales@sandlerresearch.org

  3. OTC Pharmaceuticals Market in Latin America 2014 – 2018 Key vendors dominating this space include Bayer HealthCare AG., EMS S.A., Hypermarcas S.A., and Novartis AG. Other vendors mentioned in the report are BoehringerIngelheim GmbH., Genomma Lab Internacional SAB., GlaxoSmithKline plc., Johnson & Johnson, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd. Complete report of 46 Pages is available @ http://www.sandlerresearch.org/otc-pharmaceuticals-market-in-latin-america-2014-2018.html Key questions answered in this report: What will the market size be in 2018 and what will be the growth rate? What are key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? Browse more report onPharmaceuticaland Healthcare Order this report by calling +1 888 391 5441 or Send an email to sales@sandlerresearch.orgwith your contact details and questions if any. © SandlerResearch.org/ Contact sales@sandlerresearch.org

More Related